C4 Therapeutics appoints Laura Bessen, M.D. and Donna Grogan, M.D. to board of directors

C4 Therapeutics, Inc.

Drs. Bessen and Grogan elected as directors effective July 29, 2022; Grogan Class I, Bessen Class II.
Each granted stock options for 41,200 shares under 2020 plan; one-third vests at year one, remainder quarterly.
Bessen brings two decades of medical affairs and clinical development expertise; Grogan over 25 years in drug development and regulatory strategy.
Appointments support C4T's evolution as it advances two clinical-stage programs and prepares additional candidates.
No reportable related-party transactions or arrangements per Item 404(a) of Regulation S-K.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Laura Bessen, M.D.

Director

CCCC · C4 Therapeutics, Inc.

Effective: 2022-07-29
Filed: August 2, 2022, 7:59 PM ET

On July 29, 2022, the Company’s Board of Directors (the “ Board ”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Donna Grogan, M.D. and Laura Bessen, M.D, as directors of the Company.

Appointed

Donna Grogan, M.D.

Director

CCCC · C4 Therapeutics, Inc.

Effective: 2022-07-29
Filed: August 2, 2022, 7:59 PM ET

On July 29, 2022, the Company’s Board of Directors (the “ Board ”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Donna Grogan, M.D. and Laura Bessen, M.D, as directors of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Laura Bessen, M.D. was elected as Director at C4 Therapeutics, Inc..

Action: elected
Role: Director

Exact text from the filing

On July 29, 2022, the Company’s Board of Directors (the “ Board ”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Donna Grogan, M.D. and Laura Bessen, M.D, as directors of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Donna Grogan, M.D. was elected as Director at C4 Therapeutics, Inc..

Action: elected
Role: Director

Exact text from the filing

On July 29, 2022, the Company’s Board of Directors (the “ Board ”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Donna Grogan, M.D. and Laura Bessen, M.D, as directors of the Company.

View on SEC.gov

C4 Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-22-020108

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.